Analysis of multiple steroids in saliva in the EPAD study
On 15 June, the European Prevention of Alzheimer’s Dementia (EPAD) project announced the launch of its EPAD Academy that is aiming to efficiently leverage EPAD resources to foster and develop academic research capacity and output in AD across Europe for maximum global impact. It is expected to be a great space –
- To create the next generation of AD researchers and thought leaders, by creating and facilitating opportunities for junior researchers career advancement.
- To create fair and efficient procedures for EPAD and non-EPAD research teams to access EPAD data, samples and research participants with the objective of deepening the understanding of AD onset and progression, and the factors contributing to underlying processes.
- To support the EPAD academic output in terms of scientific publications, participation in conferences and development of guidelines and studies, and to maximise their visibility and impact.
The EPAD Academy will first focus on activities to support early career researchers. For this purpose, a register of “EPAD Fellows” has been established, all of whom will be eligible for Academy activities. Applications are welcome from all EPAD partners, including EFPIA and SMEs. 19 “EPAD Fellows” applications have already been received.
For more information on the Academy, please contact: academy@ep-ad.org.
The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n°115736, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
Related posts
